Accendra Health, Inc. Accounts Receivable, Sale
Accendra Health, Inc. (ACH) reported Accounts Receivable, Sale of $542.00 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2025-10-31.
Financial Statements › Notes
us-gaap:AccountsReceivableSale · last filed 2025-10-31
- Accendra Health, Inc. accounts receivable, sale for the quarter ending 2024-09-30 was $542.00M.
- Accendra Health, Inc. accounts receivable, sale for the quarter ending 2024-06-30 was $573.00M.
- Accendra Health, Inc. accounts receivable, sale for the quarter ending 2024-03-31 was $515.00M.
- Accendra Health, Inc. accounts receivable, sale for fiscal 2023 was $1.40B.
| Period end | Accounts Receivable, Sale 3 month | Accounts Receivable, Sale 6 month | Accounts Receivable, Sale 9 month | Accounts Receivable, Sale 12 month |
|---|---|---|---|---|
| 2024-09-30 | $542.00M 10-Q · filed 2025-10-31 | $1.11B derived: sum of 2 quarters · filed 2025-10-31 | $1.60B 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $573.00M 10-Q · filed 2025-08-11 | $1.10B 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $515.00M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $1.40B 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |